Table 1.

Participant demographics

Subject	Age, yr	Sex	CV Risk	Estimated V̇o2max, ml·kg−1·min−1
Young
1	23	F	L	40.9
2	23	F	L	36.8
4	25	M	L	53.3
6	24	M	L	45.9
7	24	F	L	46.4
9	25	F	L	42.8
10	23	F	L	37.9
11	24	F	L	34.3
Older
15	67	F	H	18.3
18	65	M	H	28.0
20	66	F	H	18.9
Stroke patient
201	65	M	H	*

CV, cardiovascular; L, low; H, high; F, female; M, male.

^*The stroke participant had a low resting heart rate secondary to β-blocker use, negating estimation of V̇o_2max.